| abstract |
The present invention provides a method of treating depression, mood swings, or Alzheimer's disease in a patient in need of such treatment by administering a selective estrogen receptor modulating compound of formula (a), in which R?1 and R2¿ are independently hydroxy and alkoxy of one to four carbon atoms; and R?3 and R4¿ are independently methyl or ethyl, or R?3 and R4¿, taken together with the nitrogen atom to which they are attached, form a pyrrolidino, methyl-pyrrolidino, dimethylpyrrolidino, piperidino, morpholino, or hexamethyleneimino ring. |